Data updated: Mar 10, 2026
CHLORTHALIDONE
CHLORTHALIDONE
Approved 1981-02-26
35
Indications
--
Phase 3 Trials
45
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1981-02-26
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
WARNER CHILCOTT NOVAST LABS AMNEAL PHARMS CO ALKEM LABS LTD WATSON LABS ABBOTT DAVA PHARMS INC ANI PHARMS ZYDUS PHARMS SUPERPHARM MUTUAL PHARM KV PHARM VANGARD PUREPAC PHARM USL PHARMA APPCO UNICHEM Novartis ASCOT Teva UMEDICA PHARMOBEDIENT Viatris AIPING PHARM INC PIONEER PHARMS IPCA LABS LTD IVAX PHARMS CHARTWELL RX ALEMBIC COSETTE INVENTIA Sun Pharma SUNNY AJANTA PHARMA LTD MANKIND PHARMA
Active Ingredient: CHLORTHALIDONE
Website: ↗
CHLORTHALIDONE Approval History
Loading approval history...
What CHLORTHALIDONE Treats
35 FDA approvalsOriginally approved for its first indication in 1981 . Covers 35 distinct patient populations.
- Other (35)
Other
(35 approvals)- • Approved indication (Feb 1981)
- • Approved indication (Mar 1981)
- • Approved indication (Mar 1981)
- • Approved indication (Mar 1981)
- • Approved indication (Apr 1981)
- • Approved indication (Apr 1981)
- • Approved indication (May 1981)
- • Approved indication (Jun 1981)
- • Approved indication (Aug 1981)
- • Approved indication (Aug 1981)
- • Approved indication (Sep 1981)
- • Approved indication (Jul 1982)
- • Approved indication (Feb 1983)
- • Approved indication (Mar 1983)
- • Approved indication (Jan 1984)
- • Approved indication (Feb 1984)
- • Approved indication (May 1985)
- • Approved indication (Sep 1985)
- • Approved indication (Jul 1986)
- • Approved indication (Sep 1994)
- • Approved indication (Mar 2017)
- • Approved indication (May 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Feb 2019)
- • Approved indication (May 2019)
- • Approved indication (Jul 2019)
- • Approved indication (Aug 2019)
- • Approved indication (Feb 2020)
- • Approved indication (Nov 2020)
- • Approved indication (Jan 2022)
- • Approved indication (Feb 2022)
- • Approved indication (Feb 2022)
- • Approved indication (Aug 2022)
- • Approved indication (Aug 2022)
- • Approved indication (Nov 2024)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CHLORTHALIDONE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.